GSK

Recent Articles

10 Dangerous High-Yield Dividend Stocks to Avoid

These high-yield dividend stocks could surprise investors with dividend cuts and weak performance. Beware these siren yields! More 

16 Pharmaceuticals Stocks to Sell Now

The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

13 Pharmaceuticals Stocks to Sell Now

The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

The Hidden Upside In The Coming Mexican Crisis (HPQ, GE, GSK)

The US relationship with Mexico will change under a Trump presidency. Here are 3 possible winning stocks to consider for investment More 

GlaxoSmithKline plc (ADR) (GSK) Seeks FDA Approval for New Shingles Vaccine

GlaxoSmithKline (GSK), a healthcare company, is seeking approval from the U.S. Food and Drug Administration for a shingles vaccine. More 

7 Stocks to Sell After Hillary Clinton Wins

Hillary Clinton is the status quo candidate, but she has the biotech industry shaking in their lab coats. Sell these seven healthcare stocks! More 

11 Pharmaceuticals Stocks to Buy Now

The grades of 11 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More